• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

New device reduces acid exposure in gastroesophageal reflux disease

bys25qthea
February 22, 2013
in Chronic Disease, Gastroenterology, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Feb 22nd – Magnetic sphincter augmentation was effective in reducing esophageal acid exposure and improved quality of life in gastric reflux patients.

[tabs tab1=”2MM Rundown” tab2= “2MM Full Report”]

[tab]

Image: CC/Steven Fruitsmaak

1. Magnetic sphincter augmentation was effective in reducing esophageal acid exposure, symptoms and proton pump inhibitor (PPI) use in gastroesophageal reflux disease (GERD) patients.

This study demonstrated that magnetic augmentation of the lower esophageal sphincter could be an effective treatment for GERD. The study demonstrated both clinical reduction in acid reflux reduction and improvements in quality of life, as well as a large reduction in PPI use.

Due to the link between esophageal acid damage and cancer, magnetic sphincter augmentation is a novel treatment option that could reduce long term complications of GERD in patients that had only partial response to PPIs and cannot tolerate fundoplication or other surgeries.

RELATED REPORTS

An implantable system overcomes orthostatic hypotension in a patient with multiple-system atrophy

#VisualAbstract: Trastuzumab does not improve survival in patients with esophageal adenocarcinoma with HER2 overexpression

#VisualAbstract: Nivolumab plus chemotherapy improves progression-free survival in gastric or gastroesophageal junction cancer

Given the small sample size and the short follow-up time of only 3 years post-op, future studies of a larger scale could further establish the safety profiles as well as efficacy compared to other treatment modalities.

Click to read the study in NEJM

 [/tab]

[tab]

Image: CC/Steven Fruitsmaak

1. Magnetic sphincter augmentation was effective in reducing esophageal acid exposure and improved quality of life in gastric reflux patients.

This [prospective cohort] study investigated the effectiveness of magnetic sphincter augmentation in treating gastroesophageal reflux disease (GERD). The study followed 100 GERD patients who received laparoscopic implantation of a circular magnetic device. The device augments the lower esophageal sphincter and reduces acid reflux. The study focuses on the clinical benefits of this procedure, and no control group was established.

In terms of clinical efficacy, the procedure achieved a reduction of at least 50% esophageal acid exposure in 64% of patients (95% confidence interval [CI], 54 to 73). Additionally, the procedure achieved a reduction of 50% or more in the average daily dose of proton-pump inhibitors (PPIs) in 93% of patients (95% CI, 86 to 97).

In terms of quality of life impact, the study used GERD-Health-Related Quality of Life questionnaire to quantify improvements, with a reduction of score indicating improvement. 92% (95% CI, 85 to 97) of patients had a 50% reduction in score.

In sum: This study demonstrated that magnetic augmentation of the lower esophageal sphincter could be an effective treatment for GERD. The study demonstrated both clinical reduction in acid reflux reduction and improvements in quality of life.

Due to the link between esophageal acid damage and cancer, magnetic sphincter augmentation is a novel treatment option that could reduce long term complications of GERD in patients that had only partial response to PPIs and cannot tolerate fundoplication or other surgeries.

Given the small sample size and the short follow-up time of only 3 years post-op, future studies of a larger scale could further establish the safety profiles as well as efficacy compared to other treatment modalities.

Click to read the study in NEJM

By Xiaozhou Liu and Mitalee Patil

More from this author: Neurostimulation beneficial in Parkinson’s disease with early motor complications, Rivaroxaban has no net clinical benefit over enoxaparin for thromboprophylaxis in acutely ill patients, Long term functional outcomes similar with surgery, radiotherapy in prostate cancer patients

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain.

[/tab]

[/tabs]

Tags: deviceesophageal cancergastroesophageal reflux diseaseGERDPPI
Previous Post

Shorter telomere length linked with increased risk of common cold

Next Post

Argus retinal prosthesis "bionic eye" significantly improves vision in blind patients

RelatedReports

Increased number of daily steps linked with decreased mortality in older women
Cardiology

An implantable system overcomes orthostatic hypotension in a patient with multiple-system atrophy

May 10, 2022
#VisualAbstract: Ruxolitinib use may be associated with higher incidences of nonmelanoma skin cancers
StudyGraphics

#VisualAbstract: Trastuzumab does not improve survival in patients with esophageal adenocarcinoma with HER2 overexpression

April 27, 2022
#VisualAbstract: Solid organ transplant recipients are at an increased risk of developing non-melanoma skin cancers
StudyGraphics

#VisualAbstract: Nivolumab plus chemotherapy improves progression-free survival in gastric or gastroesophageal junction cancer

April 13, 2022
Masks for personal protection for SARS-CoV-2 infection
Chronic Disease

Oral gefapixant reduces frequency of refractory or unexplained chronic coughs

April 5, 2022
Next Post

Argus retinal prosthesis "bionic eye" significantly improves vision in blind patients

Argus retinal prosthesis "bionic eye" significantly improves vision in blind patients

Maternal asthma associated with increased odds of spontaneous abortion

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
  • Medical cannabis provides little improvement to sleep in chronic pain patients
  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.